EMvision Medical Devices (ASX:EMV) Short Percentage of Float


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
33 GF Score
Price A$1.52
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


ASX:EMV vs ABT, SYK, MDT: Short Percentage of Float Comparison

For the Medical Devices subindustry, EMvision Medical Devices's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EMvision Medical Devices Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where EMvision Medical Devices's Short Percentage of Float falls into.


ASX:EMV
33GF Score
EMvision Medical Devices Ltd ASX:EMV
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
33GF Score

Get the complete analysis for ASX:EMV

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.52
Price